Cut score vs MelaRisk
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
Cut score
Read full descriptionHide full description
The CUT score is a new cancer risk score for thyroid nodules suitable in any clinical setting. The CUT is an acronym indicating Clinical, Ultrasonographic and Thyroid cytology aspects of a thyroid nodule. The CUT score has been created to help clinicians with thyroid nodule preoperative malignancy risk assessment. This tool is intentionally developed on easily avalaible clinical data in order to allow physicians to apply the ββCUTββ score in any clinical setting using basic US technology. In the CUT score, the sum of each clinical (C) and/or ultrasonographic (U) suspicious feature results in the C+U sum, ranging from 0 to 10. This sum along with the five-tiered score of the fine-needle aspiration results (T = 1β5) determines the final ββCUTββ score of the TN. The C+U sum of the CUT score: helps to select thyroid nodules requiring fine-needle aspiration (e.g., the thyroid nodule with the highest C+U score in a multinodular goiter) when the thyroid cytology (T) is avalaible, allows to assess the risk of malignancy of the thyroid nodule in the final CUT score. The CUT score is designated exclusively for medical use and is not intended to be directly used by the patient to take any medical decision without a doctorβs advice. It has been created by the work of endocrinologists operating in the Policlinico Gemelliβs Division of Endocrinology. Itβs a medical application derived from the following published studies: Campanella P, Ianni F, Rota CA, Corsello SM, Pontecorvi A. Quantification of cancer risk of each clinical and ultrasonographic suspicious feature of thyroid nodules: a systematic review and meta-analysis. Eur J Endocrinol. 2014 Apr 10;170(5):R203-11. doi: 10.1530/EJE-13-0995. Ianni F, Campanella P, Rota CA, Prete A, Castellino L, Pontecorvi A, Corsello SM. A meta-analysis-derived proposal for a clinical, ultrasonographic, and cytological scoring system to evaluate thyroid nodules: the "CUT" score. Endocrine. 2015 Oct 30. Ianni F, Pascucci D, Paragliola RM, Rota CA, Perotti G, Fadda G, Pontecorvi A, Corsello SM. Follow-up or Surgery for Indeterminate Thyroid Nodules: Could the CUT Score Application Be a Support for Decision-Making in the Preoperative Assessment? Thyroid. 2019 Oct 23. doi: 10.1089/thy.2018.0649.
MelaRisk
Read full descriptionHide full description
This app is meant to be used only by physicians and it is not meant to make clinical decisions (the clinical usefulness of the two models has not been tested) but to be used as an informative tool to improve the predictive capability of a physician. The App is self functional and doesn't require any Internet connection.
Screenshots
Verdict
The clearest difference is update cadence: MelaRisk at every 3 days against Cut score's every 44 months. Cut score's advantage is iOS requirement (10.0 vs 12.0). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Cut score ships an update every 44 months, MelaRisk every 3 days. The most recent releases landed on September 28, 2026 and October 10, 2026 respectively.
| Parameter | Cut score | MelaRisk |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 44 months | Every 3 days β better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPod | iPhone, iPod |
| Requires iOS | 10.0 β better | 12.0 |
| Further details β not scored | ||
| Size | 8 MB | 28 MB |
| Age rating | 4+ | 12+ |
| Developer | Arianna srl | DIGITAL FOREST SRL |
In-app purchases
Cut score
No in-app purchases
MelaRisk
No in-app purchases









